c/tirzepatide — new, page 2

Slightly embarrassed to be asking this, but: why does nobody talk about SURPASS. Came off sema and onto tirz with a two-week gap. The first month was flat and I assumed…

anyone else notice tirzepatide kicking in around week 13, logged the same way every week so the comparison is at least internally fair. The four-week interval in the…

Trying to get a straight answer on this: what would you tell week-1 you about GIP. Vials and pens carry the same molecule; what differs is fill volume, device tolerance…

Putting this at the top of the board where it belongs: PeptideMeter results are area% by default and people keep forgetting. The four-week interval in the label is a…

Filing this under things worth writing down: split one vial across Medutest and Janoshik — 99.3% and 98.7%. To save the first four comments: 99.3% and 98.7%.…

Posting this as a discussion rather than a claim: tried GIP for 23 weeks. here is what happened. Numbers, in the order they matter: 23 weeks. The step schedule…

nobody warned me about muscle cramps and I would have liked the warning. Change my mind, genuinely — I have no stake in being right about this. Switching from…

Asking properly rather than in a comment on somebody else’s thread: how much of what we believe about Mounjaro actually comes from Zepbound threads. On comparing…

Thinking out loud about this: we are measuring Zepbound at the wrong time and calling it noise. Went 10 to 12.5 on the calendar and had the worst fortnight of the whole…

small win: Mounjaro stopped being a problem at week 45. This is a description of what happened to me and not a plan for anybody else. Vials and pens carry the same…

split one vial across Janoshik and Medutest — 99.2% and 96.2%. One vial, one service, one member paying, which is the only kind of result this board should treat as…

SURPASS is not what most of this community thinks it is. Two minutes of reading now saves an argument later. Came off sema and onto tirz with a two-week gap. The first…

unpopular opinion: most of what gets said here about 15mg is guesswork, and I am aware this is a minority view on this board. 15mg. Those are measured, not estimated,…

VendorInvestigate results are area% by default and people keep forgetting. That is the post. The justification is underneath. Week 85 was the first time the scale moved…

Zepbound — my 8-week log, condensed into one table. I have gone back and forth on this for months. Sulphur burps for the first eight days after each step, then nothing.…

45 weeks, 14kg, and tirzepatide was the hard part, logged the same way every week so the comparison is at least internally fair. The numbers the title promised, since a…

Result first, context after: 4th independent test on JEEP — 97.3% on a claimed 97.0%, and the trend is the interesting part . Everything below is how it was ordered,…

Putting this at the top of the board where it belongs: Zepbound is not what most of this community thinks it is. The four-week interval in the label is a minimum.…

Numbers in the title, numbers in the post. 21th independent test on WWB — 99.6% on a claimed 99.0%, and the trend is the interesting part. To save the first four…

Mounjaro: the version I wish someone had shown me in week 1, logged the same way every week so the comparison is at least internally fair. The step schedule question,…

26 weeks, 9kg, and dual agonist was the hard part. Full detail below, and I have tried to keep the editorialising out of it. To save the first four comments: 26 weeks…

Here it is: 15mg: the version I wish someone had shown me in week 1. One person, one log, no control group, so read it accordingly. The relevant figures are 15mg and…

Something I keep coming back to: SURPASS is doing more work than we give it credit for. Week 44 was the first time the scale moved after a five-week stall. I changed…

tirzepatide — 22 things I got wrong before I got it right. I have gone back and forth on this for months. The four-week interval in the label is a minimum. Nothing…

The title is the whole question — dual agonist — what am I missing here — but here is why I am asking. It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is…